Table 1.
Patients characteristics and demographics.
| Variables | All (n=8234) | Death to thyroid papillary adenocarcinoma (n=101) | Death to other reasons (n=129) |
|---|---|---|---|
| Age | 46.155±15.101 | 65.436±14.278 | 64.682±14.988 |
| Sex | |||
| Male | 1994 | 44 (2.207%) | 56 (2.808%) |
| Female | 6240 | 57 (0.913%) | 73 (1.170%) |
| Marital status | |||
| Married | 5335 | 59 (1.106%) | 77 (1.443%) |
| Unmarried | 2067 | 14 (0.677%) | 23 (1.113%) |
| DSW | 832 | 28 (3.365%) | 29 (3.486%) |
| Race | |||
| White | 6620 | 87 (1.314%) | 103 (1.556%) |
| Black | 432 | 3 (0.6945) | 10 (2.315%) |
| Asian or Pacific Islander | 1149 | 10 (0.87%) | 14 (1.218%) |
| American Indian/Alaska Native | 33 | 1 (3.030%) | 2 (6.061%) |
| Stage | |||
| Localized | 4809 | 9 (0.187%) | 72 (1.497%) |
| Regional | 3186 | 44 (1.381%) | 42 (1.318%) |
| Distant | 239 | 48 (20.084%) | 15 (6.276%) |
| Grade | |||
| 6Well differentiated | 6776 | 33 (0.487%) | 104 (1.535%) |
| Moderately differentiated | 1220 | 12 (0.984%) | 18 (1.475%) |
| Poorly differentiated | 188 | 26 (13.830%) | 5 (2.660%) |
| Undifferentiated | 70 | 30 (42.857%) | 2 (2.857%) |
| AJCC | |||
| I | 6142 | 10 (0.163%) | 62 (1.009%) |
| II | 356 | 3 (0.843%) | 12 (3.371%) |
| III | 1052 | 8 (0.760%) | 27 (2.567%) |
| IV | 684 | 80 (11.696%) | 28 (4.094%) |
| Radiation | |||
| Yes | 4230 | 68 (1.608%) | 56 (1.324%) |
| No/unknown | 4004 | 33 (0.824%) | 73 (1.8235) |
| Chemotherapy | |||
| Yes | 48 | 25 (52.083) | 1 (2.083%) |
| No/unknown | 8186 | 76 (0.928%) | 128 (1.564%) |
| Insurance | |||
| Insured | 7963 | 99 (1.243%) | 125 (1.570%) |
| Uninsured/unknown | 271 | 2 (0.738%) | 4 (1.476%) |
| Regional lymph nodes removal | |||
| Yes | 5251 | 80 (1.524%) | 80 (1.524%) |
| No | 2983 | 21 (0.704%) | 49 (1.643%) |
| Tumor size | |||
| 1–10 mm | 3020 | 6 (0.199%) | 35 (1.159%) |
| 11–20 mm | 2667 | 15 (0.562%) | 35 (1.312%) |
| 21–40 mm | 1887 | 34 (1.802%) | 33 (1.749%) |
| >40 mm | 660 | 46 (6.970%) | 26 (3.939%) |
DSW – divorced, separated or widowed.